Galectin-8 regulates primary cilium in hypothalamic neurons through anL-type calcium channel/Aurora kinaseA/HDAC6 pathway impacting body energy balance

This study demonstrates that Galectin-8 regulates primary cilium length and leptin signaling in hypothalamic neurons via an L-type calcium channel/Aurora kinase A/HDAC6 pathway, thereby influencing body energy balance and glucose homeostasis, with implications for treating metabolic diseases like obesity and type-2 diabetes.

The Gist

The Big Picture: The Body's "Smart Thermostat"

Imagine your brain has a master control center called the hypothalamus. Think of this as the body's "smart thermostat." Its job is to decide: Are we hungry? Are we full? Should we burn energy or store it?

To make these decisions, the thermostat needs to receive signals from the rest of the body. One of the most important signals comes from Leptin, a hormone released by your fat cells. Leptin is like a "fullness messenger" that tells the brain, "Hey, we have enough fuel, stop eating!"

But for the brain to hear this message clearly, it needs a special antenna. This antenna is called the Primary Cilium. It's a tiny, hair-like structure sticking out of the neurons in the hypothalamus. If the antenna is long and healthy, the brain hears the "stop eating" signal loud and clear. If the antenna is broken or too short, the brain goes deaf to the signal, leading to overeating and weight gain.

The New Villain: Galectin-8 (Gal-8)

This paper discovers a new character in this story: a protein called Galectin-8 (Gal-8).

Think of Gal-8 as a mischievous gardener. In a healthy body, this gardener's job is to trim the antennae (the cilia) so they don't get too long. However, the researchers found that when Gal-8 is present, it trims the antennae too much, making them short and ineffective.

The Experiment: What Happens When the Gardener is Gone?

The scientists created a group of mice that were born without this "gardener" (Gal-8 Knockout mice). Here is what happened:

1. The Antennas Grew Long: Without Gal-8 to trim them, the antennae on the brain cells grew very long and healthy.
2. The Brain Heard Clearly: Because the antennae were long, the brain could hear the "fullness" signal (Leptin) perfectly.
3. The Result: These mice ate less, moved around more, and stayed leaner than normal mice. They also handled sugar (glucose) much better, meaning they were less likely to get diabetes.

The Twist: When the scientists gave these "gardener-less" mice a dose of Gal-8 through their nose (like a nasal spray), the antennae got trimmed again, and the mice started acting like normal, heavier mice. This proved that Gal-8 is the direct cause of the trimming.

How Does the Gardener Do It? (The Mechanism)

The paper explains the step-by-step process of how Gal-8 shrinks the antenna. Imagine it as a domino effect:

1. The Hook: Gal-8 lands on the cell surface and grabs onto specific "hooks" called integrins (specifically $\beta1$-integrins).
2. The Alarm: This grab triggers a chain reaction inside the cell, activating two "alarm bells" called FAK and Src.
3. The Flood: These alarms open a gate called the L-type Calcium Channel. Suddenly, a flood of Calcium rushes into the cell.
4. The Demolition Crew: The calcium flood wakes up a demolition crew consisting of two proteins: Aurora Kinase A (AurkA) and HDAC6.
5. The Cut: This crew goes to the antenna, cuts the structural fibers (microtubules), and causes the antenna to shrink or disappear.

In short: Gal-8 $\rightarrow$ Grabs Hooks $\rightarrow$ Calcium Flood $\rightarrow$ Demolition Crew $\rightarrow$ Short Antenna $\rightarrow$ Brain doesn't hear "Full" $\rightarrow$ You eat more.

Why This Matters for Humans

This discovery is a big deal for two reasons:

1. Understanding Obesity: It explains why some people might have "leptin resistance" (where they have the hormone, but their brain doesn't listen). It might be because their "gardener" (Gal-8) is trimming their antennae too aggressively.
2. New Treatments: The researchers suggest we could use this knowledge to fight obesity and diabetes.
   • We could create drugs that block Gal-8, letting the antennae grow long so the brain hears the "stop eating" signal.
   • We could use existing drugs (like calcium channel blockers used for high blood pressure) to stop the calcium flood and protect the antennae.

The Takeaway

Your brain has tiny antennas that help you control your weight. A protein called Galectin-8 acts like a gardener that trims these antennas. If it trims them too much, your brain thinks you're starving even when you aren't. By understanding this "gardener," scientists hope to find new ways to help people with obesity and diabetes by helping their brains hear the "I'm full" signal again.

Technical Summary

1. Problem Statement

The hypothalamus integrates peripheral metabolic signals (such as leptin) to regulate energy balance, appetite, and glucose homeostasis. A critical structure in this process is the primary cilium (PC), a microtubule-based organelle that acts as a sensory antenna for leptin receptors.

• The Gap: While PC dysfunction is linked to obesity and type-2 diabetes (T2D), the endogenous mechanisms regulating PC structural dynamics (assembly vs. disassembly) in hypothalamic neurons remain poorly understood.
• The Hypothesis: The authors investigate Galectin-8 (Gal-8), a glycan-binding protein expressed in the hypothalamus, as a potential regulator of PC structure and leptin signaling. Previous studies suggested Gal-8 has neuroprotective roles, but its impact on metabolic regulation via cilia was unknown.

2. Methodology

The study employed a multi-faceted approach combining in vivo mouse models, in vitro cell models, and molecular signaling assays.

• In Vivo Models:

  • Subjects: Wild-type (WT) mice and Galectin-8 Knockout (Gal-8 KO) mice.
  • Intervention: Intranasal administration of recombinant Gal-8 (150 ng/day for 4 days) to Gal-8 KO mice to test reversibility.
  • Phenotyping: Measured body weight, food intake, locomotor activity, body composition (adipose tissue mass), Respiratory Exchange Ratio (RER) for fuel selection, and Glucose Tolerance Tests (GTT).
  • Histology: Immunofluorescence and immunohistochemistry of the Arcuate Nucleus (ARC) to measure PC length (using AC3 as a marker) and STAT3 phosphorylation (leptin signaling readout).

• In Vitro Models:

  • Cell Line: CLU-177 (mHypoA-2/12), an immortalized murine hypothalamic neuronal cell line retaining functional leptin receptors.
  • Treatments: Exposure to recombinant Gal-8 (30 nM), with or without specific inhibitors (FAK, Src, L-type Calcium Channel, Aurora Kinase A, HDAC6) or glycan competitors (lactose, sialyllactose).
  • Assays:
    • Imaging: Live-cell imaging (SiR-tubulin) to track PC resorption dynamics; Ratiometric calcium imaging (Fura-Red AM).
    • Biochemistry: Immunoblotting for phosphorylation states of FAK, Src, HDAC6, STAT3, and AurkA.
    • Pull-down Assays: To identify Gal-8 binding partners (integrins).
    • Shedding Analysis: Detection of acetylated $\alpha$-tubulin in conditioned media to distinguish between ciliary shedding and resorption.

3. Key Contributions

This study establishes a novel mechanistic link between extracellular glycan recognition, ciliary dynamics, and metabolic homeostasis.

1. Identification of Gal-8 as a Ciliary Regulator: Demonstrated that endogenous Gal-8 is required to maintain PC structure in hypothalamic neurons; its absence leads to abnormally long cilia.
2. Elucidation of a Signaling Cascade: Mapped a specific pathway: Gal-8 $\rightarrow$ $\beta$1-Integrins ($\alpha$3/$\alpha$5) $\rightarrow$ FAK/Src $\rightarrow$ L-type Calcium Channels (LTCC) $\rightarrow$ Calcium Influx $\rightarrow$ AurkA/HDAC6 $\rightarrow$ PC Resorption.
3. Therapeutic Reversibility: Showed that intranasal delivery of Gal-8 can restore PC length, leptin signaling, and metabolic parameters in KO mice, suggesting a non-invasive therapeutic avenue.

4. Key Results

A. In Vivo Phenotype (Gal-8 KO Mice)

• Ciliary Structure: Gal-8 KO mice exhibited significantly longer primary cilia in ARC neurons (avg. 10.64 $\mu$m) compared to WT (8.36 $\mu$m).
• Leptin Signaling: Despite longer cilia, KO mice showed increased STAT3 phosphorylation (1.8-fold), indicating enhanced leptin sensitivity.
• Metabolic Profile:
  • Phenotype: KO mice were leaner, consumed less food, and had higher locomotor activity.
  • Fuel Selection: KO mice displayed a higher Respiratory Exchange Ratio (RER ~0.95 vs. 0.87 in WT), indicating a shift toward glycolytic metabolism (carbohydrate utilization) rather than lipid oxidation.
  • Glucose Tolerance: KO mice showed significantly improved glucose tolerance (lower blood glucose peaks).
  • Adiposity: Paradoxically, despite being leaner, KO mice had increased total adipose tissue mass, suggesting altered energy utilization rather than simple caloric deficit.
• Reversibility: Intranasal Gal-8 administration to KO mice restored PC length to WT levels, normalized STAT3 signaling, and corrected the RER and metabolic phenotype.

B. In Vitro Mechanism (CLU-177 Cells)

• PC Resorption: Gal-8 treatment (30 nM) reduced the percentage of ciliated cells by ~20% and shortened ciliary length by ~22% within 2 hours.
• Mechanism of Loss:
  • Glycan Dependence: Pre-incubation with $\alpha$-lactose (blocks both CRDs) or $\alpha$2,3-sialyllactose (blocks N-terminal CRD) prevented Gal-8-induced PC loss, confirming glycan-dependent binding.
  • Integrin Interaction: Pull-down assays confirmed Gal-8 binds $\alpha$3$\beta$1 and $\alpha$5$\beta$1 integrins.
  • Signaling Cascade: Gal-8 rapidly activated FAK and Src. Inhibitors of FAK (Y15) or Src (PP2) blocked PC loss.
  • Calcium Influx: Gal-8 triggered a rapid rise in intracellular calcium. This was abolished by EGTA (extracellular calcium chelator) or Nifedipine (L-type Calcium Channel blocker), confirming LTCC dependence.
  • AurkA/HDAC6 Axis: The calcium influx activated Aurora Kinase A (AurkA), which phosphorylated HDAC6. HDAC6 then deacetylated $\alpha$-tubulin, leading to axonemal disassembly (resorption). Inhibition of AurkA (VX-680) or HDAC6 blocked Gal-8-induced ciliary loss.
• Leptin Desensitization: Gal-8 pretreatment significantly reduced leptin-induced STAT3 phosphorylation, linking ciliary resorption to reduced leptin signaling capacity.

5. Significance and Implications

• Novel Pathophysiology: The study reveals that Gal-8 acts as a "brake" on ciliogenesis in the hypothalamus. In the absence of Gal-8, cilia elongate, potentially enhancing leptin sensitivity and promoting a leaner, more active phenotype with improved glucose tolerance.
• Therapeutic Potential:
  • Metabolic Diseases: The findings suggest that modulating Gal-8 levels or inhibiting the downstream AurkA/HDAC6 axis could be a strategy to treat obesity and T2D by restoring ciliary function and leptin sensitivity.
  • Drug Repurposing: Existing drugs, such as L-type calcium channel blockers (e.g., Nifedipine) or AurkA inhibitors (used in cancer trials), could be repurposed to promote hypothalamic ciliogenesis and treat metabolic disorders.
  • Autoimmunity Link: The authors note that anti-Gal-8 autoantibodies exist in autoimmune diseases (SLE, MS). These antibodies might inadvertently block Gal-8's function in the hypothalamus, potentially contributing to metabolic dysregulation in these patients.
• Mechanistic Insight: It provides a clear molecular roadmap connecting extracellular glycan recognition to intracellular calcium flux and cytoskeletal remodeling in post-mitotic neurons.

In conclusion, this paper identifies Galectin-8 as a critical regulator of hypothalamic primary cilia, linking glycan-integrin signaling to calcium-dependent ciliary disassembly and metabolic homeostasis.